Long-term immunity and the effect of one or two booster doses with a lyophilized human rabies vaccine (human diploid cells) at 10 years post primary vaccination in China
Background: To evaluate the persistence of antibody for 10 years, and investigate the effect of one or two booster doses with Kanghua human diploid cells rabies vaccine (HDCV) in China. Methods: Participants were re-recruited at year 10 post the primary phase 3 clinical study. Some of them in Kanghu...
Saved in:
Main Authors: | Jialei Hu (Author), Shiyuan Wang (Author), Rong Zhou (Author), Hui Liu (Author), Xiaohong Gan (Author), Mingwei Wei (Author), Fengcai Zhu (Author), Fanyue Meng (Author), Wenli Hou (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pre-marketing immunogenicity and safety of a lyophilized purified human diploid cell rabies vaccine produced from microcarrier cultures: a randomized clinical trial
by: Xingyu Zhou, et al.
Published: (2019) -
Post-Marketing Surveillance of Human Rabies Diploid Cell Vaccine (Imovax) in the Vaccine Adverse Event Reporting System (VAERS) in the United States, 1990‒2015.
by: Pedro L Moro, et al.
Published: (2016) -
Effects of Antioxidants and Vitamins on the Proliferation of Human Diploid Cells
by: Gaziza Dаnlybaeva, et al.
Published: (2014) -
Novel vaccines to human rabies.
by: Hildegund C J Ertl
Published: (2009) -
Proteomic profiling of senescent human diploid fibroblasts treated with gamma-tocotrienol
by: Jen-Kit Tan, et al.
Published: (2018)